These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 20962610

  • 1. Short-term follow-up of radioembolization with yttrium-90 microspheres before liver transplantation: new perspectives in advanced hepatocellular carcinoma.
    Ettorre GM, Santoro R, Puoti C, Sciuto R, Carpanese L, Antonini M, Antonucci G, Maini CL, Miglioresi L, Vennarecci G.
    Transplantation; 2010 Oct 27; 90(8):930-1. PubMed ID: 20962610
    [No Abstract] [Full Text] [Related]

  • 2. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.
    Iñarrairaegui M, Pardo F, Bilbao JI, Rotellar F, Benito A, D'Avola D, Herrero JI, Rodriguez M, Martí P, Zozaya G, Dominguez I, Quiroga J, Sangro B.
    Eur J Surg Oncol; 2012 Jul 27; 38(7):594-601. PubMed ID: 22440743
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of radioembolization in identifying patients with favorable tumor biology before living donor liver transplantation.
    Yu YD, Kim DS, Jung SW, Kim Y, Suh SO.
    Transplantation; 2014 Sep 15; 98(5):e47-50. PubMed ID: 25171535
    [No Abstract] [Full Text] [Related]

  • 4. Downstaging of bilobar hepatocellular carcinoma after radioembolization with 90Y microspheres as a bridge to liver transplantation.
    Reguera-Berenguer L, Orcajo-Rincón J, Rotger-Regí A, Matilla-Peña AM, Echenagusia-Boyra M, Pérez-Pascual R, Marí-Hualde A, Alonso-Farto JC.
    Rev Esp Med Nucl Imagen Mol; 2017 Sep 15; 36(5):329-332. PubMed ID: 28268101
    [Abstract] [Full Text] [Related]

  • 5. Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.
    Khalaf H, Alsuhaibani H, Al-Sugair A, Al-Mana H, Al-Mutawa A, Al-Kadhi Y, Al-Sebayel M.
    Transplant Proc; 2010 Apr 15; 42(3):994-8. PubMed ID: 20430224
    [Abstract] [Full Text] [Related]

  • 6. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
    Ho S, Lau WY, Leung WT.
    Chin Med J (Engl); 2001 Apr 15; 114(4):433-4. PubMed ID: 11780473
    [No Abstract] [Full Text] [Related]

  • 7. Yttrium-90 radioembolization for the treatment of primary and metastatic liver tumors.
    Sato KT.
    Semin Roentgenol; 2011 Apr 15; 46(2):159-65. PubMed ID: 21338841
    [No Abstract] [Full Text] [Related]

  • 8. Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.
    Kulik LM, Mulcahy MF, Hunter RD, Nemcek AA, Abecassis MM, Salem R.
    Liver Transpl; 2005 Sep 15; 11(9):1127-31. PubMed ID: 16123954
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
    Antoch G, Mueller SP, Hamami M, Heusner TA, Ertle J, Hilgard P, Forsting M, Bockisch A.
    Rofo; 2010 Aug 15; 182(8):660-70. PubMed ID: 20405369
    [Abstract] [Full Text] [Related]

  • 14. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X, He N, Sun J, Tan J, Zhang C, Yang J, Lu T, Li J.
    Chin Med J (Engl); 1999 May 15; 112(5):430-2. PubMed ID: 11593513
    [Abstract] [Full Text] [Related]

  • 15. Reply: selection criteria for liver transplantation in patients with hepatocellular carcinoma: beyond tumor size and number?
    Otto G.
    Liver Transpl; 2007 Mar 15; 13(3):470-1. PubMed ID: 17318868
    [No Abstract] [Full Text] [Related]

  • 16. Downstaging Hepatocellular Carcinoma with Yttrium-90 radioembolization: resection or transplantation?
    Ettorre GM, Laurenzi A, Vennarecci G.
    Eur J Surg Oncol; 2014 Jun 15; 40(6):789-90. PubMed ID: 24572481
    [Abstract] [Full Text] [Related]

  • 17. Superselective yttrium-90 radioembolization for hepatocellular carcinoma in high-risk cases: another tool in the toolbox.
    Brown KT.
    J Vasc Interv Radiol; 2014 Jul 15; 25(7):1073-4. PubMed ID: 24968727
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Yttrium-90 Transarterial Radioembolization: An Effective Primary or Salvage Therapy to Bridge the Patients with Hepatocellular Carcinoma to Liver Transplantation.
    Qu X, Zhang F.
    Acad Radiol; 2024 May 15; 31(5):1836-1838. PubMed ID: 38472023
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.